… COVID-19 and AD and thus impact on eradicating the ongoing global threat. Thus, people
suffering from COVID-19 … of developing AD or already suffering from AD, would be benefitted. …

… the symptoms and pathogenesis of COVID-19 and AD. Next, we … COVID-19 and the underlying
mechanisms from molecular to social levels. We also highlight the influence of COVID-19 …

… In summary, the inconsistency in the findings related to the association between APOE gene
polymorphism and COVID-19 risk and severity may be due to the differences in the genetic …

… In another study, researchers attempt to determine the neurochemical crosstalk between
AD and COVID-19. According to studies, during the invasion, SARS-CoV-2 stimulates a …

… are likely to be infected with SARS-CoV-2 and, eventually, worsen their condition, so we
first compared the cohorts of control against COVID-19 and then AD against AD+COVID-19 …

… a neuropathological cross-talk takes place between the coronavirus disease 2019 (COVID-19)
-… detailed insights into the neurochemical interplay occurring between COVID-19 and AD, …

… evidence on common pathways between COVID-19 and Alzheimer's disease (AD)[3], we …
IFITM3’s membrane localization [4,5] is accordingly perturbed in both AD and COVID-19 …

… COVID-19, and develop more severe forms and worse outcomes, including death. Therefore,
understanding shared links between COVID-19 and … A neurochemical study reported that …

… coronavirus 2 (SARS-CoV-2), the etiologic agent of the 2019 coronavirus disease (COVID-19), …
Neurochemical cross-talk between coronavirus disease 2019 and Alzheimer’s disease …

… Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in late 2019 as
… disease 2019 (COVID-19), resulting in a broad spectrum of symptoms ranging from fevers to …